Patent US2460530A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4462941A Expired / Lapsed US ⏱️ 0.0 years remaining

Dynorphin amide analogs

Assignee: DYNORPHIN PARTNERSHIP A PARTNERSHIP OF CALIFORNIA
•
Filing: 1982-06-10
•
Granted: 1984-07-31
•
Expires: 2002-06-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Dynorphin(1-13) has been previously reported to antagonize the analgesia induced by narcotics in naive hosts. Novel compounds are provided which differ from dynorphin(1-13) by neither potentiating nor antagonizing narcotics, such as morphine, in naive animals. In tolerant hosts the new compounds potentiate narcotic or peptide induced analgesia, and in addition are less susceptible to degradation than dynorphin(1-13). Particularly preferred of the new compounds are polypeptides having ten amino acids with nitrogen containing moieties at both termini.

Inventors

  • 👤 Nancy M. Lee
  • 👤 Horace H. Loh
  • 👤 Jaw-Kang Chang

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 12:01
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/435; C07K14/665; A; A61; A61P; A61P25/00; A61P25/04; A61K; A61K38/00

Claims Analysis

Total Claims: 5
Claim 1
Independent Claim 41 words
A dynorphin analog having the sequence TYR-GLY-GLY-PHE-LEU-ARG-ARG-AA 8 -AA 9 -AA 10 wherein AA 8 is isoleucine, leucine or lysine, AA 9 is arginine or proline, AA 10 is proline and a carbonyl carbon at the AA 10 terminus is amidated.
Claim 2
Dependent Claim 41 words
A dynorphin analog having the sequence TYR-GLY-GLY-PHE-LEU-ARG-ARG-AA 8 -AA 9 -AA 10 wherein AA 8 is isoleucine, leucine or lysine, AA 9 is arginine or proline, AA 10 is proline and a carbonyl carbon at the AA 10 terminus is amidated.
Claim 3
Dependent Claim 22 words
A polypeptide having the sequence TYR-GLY-GLY-PHE-LEU-ARG-ARG-AA 8 -ARG-PRO wherein the proline thereof is amidated and AA 8 is tyrosine, isoleucine or lysine.
Claim 4
Dependent Claim 22 words
A polypeptide having the sequence TYR-GLY-GLY-PHE-LEU-ARG-ARG-AA 8 -ARG-PRO wherein the proline thereof is amidated and AA 8 is tyrosine, isoleucine or lysine.
Claim 5
Dependent Claim 11 words
The polypeptide as in claim 2 wherein AA 8 is isoleucine.

References Cited (Backward Citations)

EP0029300A1 Cited
US4396606A Cited
US4361553A Cited
EP0070569A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1987-07-31 1988-01-30 1988-07-31 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1991-07-31 1992-01-30 1992-07-31 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1995-07-31 1996-01-30 1996-07-31 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag